Qingshan Li

机构：Suizhou Central Hospital · ORCID：0000-0002-5564-0860

发表论文 34 篇 · 总被引 415 次 · h-index 11

代表论文

• First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial (2025 · Nature Medicine · 被引 88)
• First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study (2024 · Nature Medicine · 被引 56)
• Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial (2025 · Nature Medicine · 被引 30)
• Anti-swelling and photoresponsive MXene-based polyampholyte hydrogel sensors for underwater positioning and urban waterlogging pre-warning (2024 · Journal of Materials Chemistry A · 被引 20)
• A robust and adhesive anti-swelling hydrophobic ionogel with prolonged stability for strain and temperature sensors (2024 · Journal of Materials Chemistry A · 被引 17)
• Risk factors and predictive models for frozen shoulder (2024 · Scientific Reports · 被引 13)